4.6 Article

Differential Effects of Ceramide and Sphingosine 1-Phosphate on ERM Phosphorylation PROBING SPHINGOLIPID SIGNALING AT THE OUTER PLASMA MEMBRANE

期刊

JOURNAL OF BIOLOGICAL CHEMISTRY
卷 285, 期 42, 页码 32476-32485

出版社

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M110.141028

关键词

-

资金

  1. National Institutes of Health [CA87584, CA97132]

向作者/读者索取更多资源

ERM proteins are regulated by phosphorylation of the most C-terminal threonine residue, switching them from an activated to an inactivated form. However, little is known about the control of this regulation. Previous work in our group demonstrated that secretion of acid sphingomyelinase acts upstream of ERM dephosphorylation, suggesting the involvement of sphingomyelin (SM) hydrolysis in ERM regulation. To define the role of specific lipids, we employed recombinant bacterial sphingomyelinase (bSMase) as a direct probe of SM metabolism at the plasma membrane. bSMase induced a rapid dose-and time-dependent decrease in ERM dephosphorylation. ERM dephosphorylation was driven by ceramide generation and not by sphingomyelin depletion, as shown using recombinant sphingomyelinase D. The generation of ceramide at the plasma membrane was sufficient for ERM regulation, and no intracellular SM hydrolysis was required, as was visualized using Venus-tagged lysenin probe, which specifically binds SM. Interestingly, hydrolysis of plasma membrane bSMase-induced ceramide using bacterial ceramidase caused ERM hyperphosphorylation and formation of cell surface protrusions. The effects of plasma membrane ceramide hydrolysis were due to sphingosine 1-phosphate formation, as ERM phosphorylation was blocked by an inhibitor of sphingosine kinase and induced by sphingosine 1-phosphate. Taken together, these results demonstrate a new regulatory mechanism of ERM phosphorylation by sphingolipids with opposing actions of ceramide and sphingosine 1-phosphate. The approach also defines a tool kit to probe sphingolipid signaling at the plasma membrane.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Functions of neutral ceramidase in the Golgi apparatus

Wataru Sakamoto, Nicolas Coant, Daniel Canals, Lina M. Obeid, Yusuf A. Hannun

JOURNAL OF LIPID RESEARCH (2018)

Article Biochemistry & Molecular Biology

Probing compartment-specific sphingolipids with targeted bacterial sphingomyelinases and ceramidases[S]

Wataru Sakamoto, Daniel Canals, Silvia Salamone, Janet Allopenna, Christopher J. Clarke, Justin Snider, Lina M. Obeid, Yusuf A. Hannun

JOURNAL OF LIPID RESEARCH (2019)

Article Biochemistry & Molecular Biology

PKCα is required for Akt-mTORC1 activation in non-small cell lung carcinoma (NSCLC) with EGFR mutation

Mohamed F. Salama, Mengling Liu, Christopher J. Clarke, Mel Pilar Espaillat, John D. Haley, Ting Jin, Daifeng Wang, Lina M. Obeid, Yusuf A. Hannun

ONCOGENE (2019)

Article Multidisciplinary Sciences

Replacing plasma membrane outer leaflet lipids with exogenous lipid without damaging membrane integrity

Guangtao Li, Shinako Kakuda, Pavana Suresh, Daniel Canals, Silvia Salamone, Erwin London

PLOS ONE (2019)

Article Biochemistry & Molecular Biology

Ceramide launches an acute anti-adhesion pro-migration cell signaling program in response to chemotherapy

Daniel Canals, Silvia Salamone, Bruno Jaime Santacreu, Erika Nemeth, Daniel Aguilar, Maria Jose Hernandez-Corbacho, Mohamad Adada, Daniela I. Staquicini, Wadih Arap, Renata Pasqualini, John Haley, Lina M. Obeid, Yusuf A. Hannun

FASEB JOURNAL (2020)

Article Cell Biology

Targeting acid ceramidase inhibits YAP/TAZ signaling to reduce fibrosis in mice

Sarah Alsamman, Stephanie A. Christenson, Amy Yu, Nadia M. E. Ayad, Meghan S. Mooring, Joe M. Segal, Jimmy Kuang-Hsien Hu, Johanna R. Schaub, Steve S. Ho, Vikram Rao, Megan M. Marlow, Scott M. Turner, Mai Sedki, Lorena Pantano, Sarani Ghoshal, Diego Dos Santos Ferreira, Hsiao-Yen Ma, Caroline C. Duwaerts, Regina Espanol-Suner, Lan Wei, Benjamin Newcomb, Izolda Mileva, Daniel Canals, Yusuf A. Hannun, Raymond T. Chung, Aras N. Mattis, Bryan C. Fuchs, Andrew M. Tager, Dean Yimlamai, Valerie M. Weaver, Alan C. Mullen, Dean Sheppard, Jennifer Y. Chen

SCIENCE TRANSLATIONAL MEDICINE (2020)

Article Biochemistry & Molecular Biology

Ceramide synthase 2-C24:1-ceramide axis limits the metastatic potential of ovarian cancer cells

Xuewei Zhang, Wataru Sakamoto, Daniel Canals, Masumi Ishibashi, Masaya Matsuda, Kentaro Nishida, Masafumi Toyoshima, Shogo Shigeta, Makoto Taniguchi, Can E. Senkal, Toshiro Okazaki, Nobuo Yaegashi, Yusuf A. Hannun, Takeshi Nabe, Kazuyuki Kitatani

Summary: Regulation of sphingolipid metabolism has a significant impact on cellular homeostasis and cancer progression. Dysregulation of ceramide-centered metabolism is associated with metastatic potential in ovarian cancer cells. Specifically, the CerS2-C-24:1-ceramide axis, possibly counteracted by neutral ceramidase, plays a key role in limiting cell motility and metastatic potential.

FASEB JOURNAL (2021)

Article Cell Biology

Targeting sphingosine kinase 1 (SK1) enhances oncogene-induced senescence through ceramide synthase 2 (CerS2)-mediated generation of very-long-chain ceramides

Magali Trayssac, Christopher J. Clarke, Jeffrey L. Stith, Justin M. Snider, Naomi Newen, Christopher R. Gault, Yusuf A. Hannun, Lina M. Obeid

Summary: Senescence is an antiproliferative mechanism that can suppress tumor development and be induced by oncogenes like genes of the Ras family. Targeting SK1 could potentially enhance oncogene-induced senescence by increasing VLC Cer downstream of CerS2.

CELL DEATH & DISEASE (2021)

Article Biochemistry & Molecular Biology

The doxorubicin-induced cell motility network is under the control of the ceramide-activated protein phosphatase 1 alpha

Daniel Canals, Silvia Salamone, Bruno Jaime Santacreu, Daniel Aguilar, Maria Jose Hernandez-Corbacho, Anne G. Ostermeyer-Fay, Meaghan Greene, Erika Nemeth, John D. Haley, Lina M. Obeid, Yusuf A. Hannun

Summary: The study revealed that low doses of the chemotherapeutic compound doxorubicin result in dysregulation of cytoskeletal proteins, enhancing cancer cell migration, which could explain the reported effects of doxorubicin worsening cancer metastasis in animal models.

FASEB JOURNAL (2021)

Editorial Material Medicine, General & Internal

Peeking inside the sphingolipid network in lung cancer Comment

Daniel Canals

EBIOMEDICINE (2021)

Article Biochemistry & Molecular Biology

A simple, highly sensitive, and facile method to quantify ceramide at the plasma membrane

Meaghan Greene, Maria Jose Hernandez-Corbacho, Anne G. Ostermeyer-Fay, Yusuf A. Hannun, Daniel Canals

Summary: The role of ceramide in biological functions has been mainly studied by measuring its elevation in the total cell lysate using LC-MS. However, it is now recognized that ceramide in different subcellular organelles regulates specific functions. In the plasma membrane, even though the changes in ceramide levels may be a small fraction of the total cellular ceramide, they play a critical role in cell signaling. Currently, there are no efficient techniques to quantify ceramide specifically in the plasma membrane. This study presents a novel method to measure ceramide mass in the plasma membrane, allowing for investigation of sphingolipid compartmentalization and function.

JOURNAL OF LIPID RESEARCH (2023)

Article Oncology

Sublethal doxorubicin promotes migration and invasion of breast cancer cells: role of Src Family non-receptor tyrosine kinases

Samia Mohammed, Achraf A. Shamseddine, Benjamin Newcomb, Ronald S. Chavez, Tyler D. Panzner, Allen H. Lee, Daniel Canals, Chioma M. Okeoma, Christopher J. Clarke, Yusuf A. Hannun

Summary: Sublethal doses of Doxorubicin induce increased migration and invasion in cancer cells, independent of EMT and cancer stem cell population. Activation of SFKs, including Fyn, Yes, and Src, partly in a p53 and ATR-dependent manner, mediates these effects. Inhibiting SFKs with Dasatinib offers a potential therapeutic strategy to mitigate local invasion.

BREAST CANCER RESEARCH (2021)

暂无数据